Leica Microsystem's Portfolio to Include Entire Histo-Pathology Process

By Labmedica staff writers
Posted on 02 Aug 2007

Leica Microsystems (Wetzlar, Germany) has started to integrate Vision BioSystems with its own sectioning and specimen processing business, to form a new division, which will operate alongside the company.

There are another three customer-segmented divisions that serve industrial, life science research, and surgical customers. Combining the product ranges of VisionSystems (Melbourne, Australia) with Leica Microsystems, the Biosystems division will be able to offer instruments for the histo-pathology process, as well as the Novocastra's (Newcastle, UK) range of antibodies and reagents. The key focus of the division will be to develop innovative, automated systems to improve productivity and enhance quality for customers.

"The combined expertise of these two businesses located at sites in Germany, Australia, and the UK has created the most powerful force in the development of histo-pathology solutions worldwide,” emphasizes Anne De Greef-Safft, Biosystems Division president.
The existing product factories in Melbourne, Australia, Newcastle, United Kingdom, together with the German site in Nussloch will continue manufacturing for the division.

Related Links:
Leica Microsystems
VisionSystems
Novocastra